Atlas Trials

A Phase II Prospective Trial of mXELOXIRI Reintroduction for mCRC

Clinical trial NCT04508452 · UNKNOWN

Trial details

NCT number
NCT04508452
Sponsor
First Affiliated Hospital of Zhejiang University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Unresectable Metastatic Colorectal Carcinoma
Start date
2020-05-18
Primary completion
2022-06-01
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.